Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Active, Not Recruiting

PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin

NCT05810870

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +6 more
Locations
  • Hospital Universitario Clínico San Cecilio de Granada Granada, Andalusia, Spain
  • Hospital Universitario Virgen del Rocio Seville, Andalusia, Spain
  • Onkologikoa Donostia / San Sebastian, Basque Country, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

NCT05721248

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Mayo Clinic Hospital Arizona Phoenix, Arizona, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Mayo Clinical Hospital Florida Jacksonville, Florida, United States
  • Dana-Farber Cancer Insitute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

NCT05892068

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Memorial Sloan Kettering Cancer Center (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Onvansertib + Paclitaxel In TNBC

NCT05383196

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Northwestern Medicine Cancer Centers Warrenville, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, Not Recruiting

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

NCT04639986

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, China
  • Chinese PLA General Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 43 locations
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

NCT02747004

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • The Center for Cancer and Blood Disorders Fort Worth, Texas, United States
View all 59 locations
View Trial Details

Related conditions